Joshua R. Disbrow

CIK 1566240 · Chief Executive Officer · last filed 2026-03-27

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$445.5K

Companies

3

Total Filings

38

Lifetime Open-Market Net

$432.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AYTU Chief Executive Officer 207,203 $2.15 $445.5K $373.8K 17 2025-10-07
ZYNEX INC (ZYXI) Delisted Director 22,500 $0.13 $2.9K $58.2K 7 2025-05-16
Ampio Pharmaceuticals, Inc. (AMPE) Delisted Chief Operating Officer $0.18 $0 2 2013-11-27

Recent Filings · Page 2 of 4

38 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-06-15 AYTU Buy (P) +14,000 $26.1K EDGAR
2022-12-23 AYTU Disp (D) −80,000 $0 EDGAR
2022-12-21 AYTU Buy (P) +112,371 $25.0K EDGAR
2022-11-28 AYTU Buy (P) +222,000 $52.6K EDGAR
2022-11-21 AYTU Grant (A) +222,000 $52.6K EDGAR
2022-06-02 ZYNEX INC (ZYXI) Delisted Grant (A) +10,000 $0 EDGAR
2021-07-19 ZYNEX INC (ZYXI) Delisted Grant (A) +10,000 $0 EDGAR
2021-04-16 AYTU Grant (A) +800,000 $0 EDGAR
2020-07-30 ZYNEX INC (ZYXI) Delisted Grant (A) +20,000 $0 EDGAR
2020-06-12 AYTU Grant (A) +450,000 $0 EDGAR
Showing 1120 of 38
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.